Natee Jearawiriyapaisarn

25/25 Phuttamonthon 4 Road
Salaya, 73170, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34+ hematopoietic stem/progenitor cells.

Establishment of a human induced pluripotent stem cell line MUi036-A from healthy male CD34+ hematopoietic stem/progenitor cells.

Journal: Stem cell research

Published: April 03, 2026

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells.

Journal: Molecular medicine (Cambridge, Mass.)

Published: June 30, 2025

Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals.

Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals.

Journal: Scientific reports

Published: January 21, 2025

Precise correction of G6PD Viangchan mutation in iPSCs by prime editing strategy.

Precise correction of G6PD Viangchan mutation in iPSCs by prime editing strategy.

Journal: Scientific reports

Published: November 12, 2024

Generation of an EYS-associated retinitis pigmentosa patient-derived human pluripotent stem cell line (MUi038-A).

Generation of an EYS-associated retinitis pigmentosa patient-derived human pluripotent stem cell line (MUi038-A).

Journal: Stem cell research

Published: March 20, 2024

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients.

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients.

Journal: Orphanet journal of rare diseases

Published: February 16, 2024

miR-214 aggravates oxidative stress in thalassemic erythroid cells by targeting ATF4.

miR-214 aggravates oxidative stress in thalassemic erythroid cells by targeting ATF4.

Journal: PloS one

Published: October 04, 2023

Recombinant Cas9 protein production in an endotoxin-free system and evaluation with editing the BCL11A gene in human cells.

Recombinant Cas9 protein production in an endotoxin-free system and evaluation with editing the BCL11A gene in human cells.

Journal: Protein expression and purification

Published: April 20, 2023

A generation of human-induced pluripotent stem cell line (MUi032-A) from a Choroideremia disease patient carrying a hemizygous mutation on the CHM gene.

A generation of human-induced pluripotent stem cell line (MUi032-A) from a Choroideremia disease patient carrying a hemizygous mutation on the CHM gene.

Journal: Stem cell research

Published: September 30, 2022

Identification of novel γ-globin inducers among all potential erythroid druggable targets.

Identification of novel γ-globin inducers among all potential erythroid druggable targets.

Journal: Blood advances

Published: December 09, 2021

Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.

Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.

Journal: PloS one

Published: November 10, 2021

Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β0-thalassemia/hemoglobin E erythroid cells.

Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β0-thalassemia/hemoglobin E erythroid cells.

Journal: Hematology reports

Published: April 26, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026